SOX8 promotes cetuximab resistance via HGF/MET bypass pathway activation in colorectal cancer
Author:
Funder
Liaoning S&T Project
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s00280-021-04378-z.pdf
Reference32 articles.
1. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics 2020. CA Cancer J Clin 70(1):7–30. https://doi.org/10.3322/caac.21590
2. Cohen R, Pudlarz T, Delattre JF, Colle R, André T (2020) Molecular targets for the treatment of metastatic colorectal cancer. Cancers. https://doi.org/10.3390/cancers12092350
3. Mendelsohn J (2002) Targeting the epidermal growth factor receptor for cancer therapy. J Clin Oncol Off J Am Soc Clin Oncol 20(18 Suppl):1s–13s
4. Price TJ, Tang M, Gibbs P, Haller DG, Peeters M, Arnold D, Segelov E, Roy A, Tebbutt N, Pavlakis N, Karapetis C, Burge M, Shapiro J (2018) Targeted therapy for metastatic colorectal cancer. Expert Rev Anticancer Ther 18(10):991–1006. https://doi.org/10.1080/14737140.2018.1502664
5. Berger MD, Ning Y, Stintzing S, Heinemann V, Cao S, Zhang W, Yang D, Miyamoto Y, Suenaga M, Schirripa M, Hanna DL, Soni S, Puccini A, Tokunaga R, Naseem M, Battaglin F, Cremolini C, Falcone A, Loupakis F, Lenz HJ (2020) A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials. Eur J Cancer 131:89–97. https://doi.org/10.1016/j.ejca.2020.02.048
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer;Cellular and Molecular Life Sciences;2024-01-12
2. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling;Frontiers in Pharmacology;2024-01-10
3. EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma;Oral Oncology;2023-07
4. From classic medicinal chemistry to state‐of‐the‐art interdisciplinary medicine: Recent advances in proteolysis‐targeting chimeras technology;Interdisciplinary Medicine;2023-04
5. Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis;Bosnian Journal of Basic Medical Sciences;2022-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3